Bicalutamide in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2021-06-24
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can cause the growth of breast cancer cells. Antihormone therapy, such
as bicalutamide, may stop the adrenal glands from making androgens.
PURPOSE: This phase II trial is studying how well bicalutamide works in treating patients
with metastatic breast cancer.